Video: Knock on Wood| Webinar: ACR/CHEST ILD Guidelines in Practice
fa-facebookfa-linkedinfa-youtube-playfa-rss

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • QA/QI
    • Technology
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

Search results for: liver

Complications to Watch for in Pregnant Rheumatology Patients

Anat Chemerinski, MD, & Jason Liebowitz, MD  |  November 18, 2018

BALTIMORE—Understanding issues regarding pregnancy in women with rheumatic disease is important to patients and physicians alike, said Bonnie Bermas, MD, the Dr. Morris Ziff Distinguished Professor in Rheumatology at UT Southwestern Medical Center, Dallas, in her recent lecture at the Maryland Society for the Rheumatic Diseases.The physiologic changes in normal pregnancy, which include increased circulating…

Filed under:ConditionsMeeting Reports Tagged with:pregnancy

New RheumPAC Chair Zachary Wallace, MD, MSc, Promotes a Louder Voice for Rheumatology

Kelly Tyrrell  |  November 13, 2018

A patient Zachary Wallace, MD, MSc, met during his third year of medical school at Georgetown University helped lead him to his passion for rheumatology. He was completing a clinical rotation in medicine, and the experience made rheumatologic disease tangible for him. “She had lupus, and I became interested in her case,” he says. Later,…

Filed under:Profiles Tagged with:RheumPAC chairZachary Wallace

Mirtazapine Ineffective for Fibromyalgia

Lara C. Pullen, PhD  |  November 5, 2018

Mirtazapine has been prescribed off-label to fibromyalgia patients who have not responded to other treatments. However, a recent systemic review found no difference between mirtazapine and placebo for these patients, and any potential benefits from mirtazapine may not outweigh its potential harm, including drowsiness, weight gain and liver damage…

Filed under:ConditionsPain Syndromes Tagged with:Fibromyalgiamirtazapineoff-label drugsPainPain Management

Q&A with New ACR President Paula Marchetta

Kelly Tyrrell  |  October 23, 2018

Paula Marchetta, MD, MA, MBA, became a member of the ACR in 1989, during her rheumatology fellowship at Bellevue Hospital and the New York University (NYU) Medical Center. Just 10 years earlier, rheumatology had been an unlikely path. Dr. Marchetta—with a love of the arts—was pursuing Bachelor’s and Master’s degrees in English. But she found…

Filed under:Profiles Tagged with:ACR presidentPaula Marchetta

Plaque Psoriasis Treatments: BMS-986165 Promising & Adalimumab Biosimilar Demonstrates Equivalence

Michele B. Kaufman, PharmD, BCGP  |  October 22, 2018

According to new data, BMS-986165, an oral, selective tyrosine kinase 2 inhibitor, may be safe and effective for treating plaque psoriasis…

Filed under:Biologics/DMARDsDrug Updates Tagged with:adalimumabadalimumab-adbmBMS-986165plaque psoriasisTYK2 inhibitortyrosine kinase 2 inhibitor

ARHP Lifetime Achievement Award Winner: Christina H. Opava, PhD, RPT

Keri Losavio  |  October 22, 2018

CHICAGO—Christina H. Opava, PhD, RPT, is the recipient of the 2018 ARHP Lifetime Achievement Award, which was presented (along with the other ACR and ARHP awards) during the opening session of the 2018 ACR/ARHP Annual Meeting on Oct. 20. “Receiving this award is an immense honor,” she tells The Rheumatologist. “My first thought was that…

Filed under:American College of RheumatologyAwardsMeeting ReportsProfessional TopicsProfiles Tagged with:2018 ACR/ARHP Annual MeetingAssociation of Rheumatology Professionals (ARP)AwardsOpava

Ethics Forum: When & How to Intervene with the Impaired Colleague

Jill Johnson, MD  |  October 18, 2018

You are seeing a hospital consult late in the afternoon on a Saturday. The patient has suspected, new-onset lupus with inflammatory arthritis, renal failure with nephrotic range proteinuria and a malar rash. You plan to start the patient on high-dose IV steroids, and you decide to speak to the nephrologist on call first. When he…

Filed under:EthicsLegal Updates Tagged with:colleaguereportingsupervisor

Awards, Appointments & Announcements in the World of Rheumatology

Ann-Marie Lindstrom  |  October 18, 2018

Canadian Pediatric Rheumatologist Invested into Order of Canada Peter Dent, MD, professor emeritus of pediatrics at McMaster University in Hamilton, Ontario, Canada, was invested into the Order of Canada in May. The Order of Canada is the country’s highest civilian honor. “Dr. Dent has had a substantial positive impact on healthcare, in Hamilton and far…

Filed under:AwardsProfiles Tagged with:CanadaDr. Latifa FakoyaDr. Peter DentDr. Ross Petty

Trimethoprim-Sulfamethoxazole Prophylaxis Reduced Rituximab Infection Risk

Kathy Holliman  |  October 18, 2018

Severe infections occurred in 25% of patients with anti-neutrophil cytoplasm antibody (ANCA) associated vasculitis (AAV) who were treated with rituximab, according to results of an observational study conducted in the United Kingdom (U.K.) and Austria. Trimethoprim-sulfamethoxazole (TMP/SMX) prophylaxis, however, reduced the risk of severe infections, the investigators reported in Annals of the Rheumatic Diseases.1 Andreas…

Filed under:ConditionsDrug UpdatesVasculitis Tagged with:antibody-associated vasculitisInfectionrituximab

8 Ways to Help Your Patients with Medication Costs

Vanessa Caceres  |  October 18, 2018

A patient with rheumatoid arthritis (RA) comes to your office and needs a medication. You prescribe it, and the patient’s insurance plan covers it. The patient begins the medication and slowly but surely feels better. Prescribing drugs for a patient should be this simple but rarely is, thanks to the high cost of drugs and…

Filed under:Drug UpdatesPatient PerspectivePractice Support Tagged with:cost savingdrug costs

  • « Previous Page
  • 1
  • …
  • 48
  • 49
  • 50
  • 51
  • 52
  • …
  • 125
  • Next Page »
  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
fa-facebookfa-linkedinfa-youtube-playfa-rss
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences